Multiple Acquired Mutations Captured by Liquid Biopsy in the EGFR Addicted Metastatic Colorectal Cancer
Open Access
- 24 July 2021
- journal article
- editorial
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 20 (4), 354-358
- https://doi.org/10.1016/j.clcc.2021.07.005
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comprehensive Analysis of Hypermutation in Human CancerCell, 2017
- Liquid biopsies come of age: towards implementation of circulating tumour DNANature Reviews Cancer, 2017
- Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancerNature Communications, 2016
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancerAnnals of Oncology, 2016
- Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015Journal of Clinical Oncology, 2016
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patientsNature Medicine, 2015
- Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal CancerClinical Cancer Research, 2015
- Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancerOncotarget, 2015
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerNature, 2012
- Monoclonal antibodies in the treatment of metastatic colorectal cancer: A reviewClinical Therapeutics, 2010